DSC Equity Fund – Healthcare A|A

Reference Data

ISIN AT0000A1FNT0
Valor Number 28871817
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A|A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 193.76 CHF 03.07.2025
Previous Price * 195.58 CHF 02.07.2025
52 Week High * 246.77 CHF 03.09.2024
52 Week Low * 193.37 CHF 01.07.2025
NAV * 193.76 CHF 03.07.2025
Issue Price * 199.58 CHF 03.07.2025
Redemption Price * 193.76 CHF 03.07.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 41,387,253
Unit/Share Assets *** 29,612,632
Trading Information SIX

Performance

YTD Performance -13.46% 30.12.2024
03.07.2025
1 month -1.81% 03.06.2025
03.07.2025
3 months -13.95% 03.04.2025
03.07.2025
6 months -13.52% 03.01.2025
03.07.2025
1 year -18.64% 03.07.2024
03.07.2025
2 years -12.23% 03.07.2023
03.07.2025
3 years -15.97% 04.07.2022
03.07.2025
5 years -9.98% 03.07.2020
03.07.2025

Tax Data

Equity Participation Rate in % 103.31
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Johnson & Johnson 6.93%
Eli Lilly and Co 6.71%
Abbott Laboratories 5.20%
AbbVie Inc 4.30%
UnitedHealth Group Inc 3.88%
Merck & Co Inc 3.63%
Sanofi SA 3.46%
AstraZeneca PLC 3.43%
Intuitive Surgical Inc 3.39%
iShares MSCI Wld HlthCrSect AdvcdETF$Inc 3.17%
Last data update 31.05.2025

Cost / Risk

TER 1.53%
TER date 30.04.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.52%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)